Increase in serum amyloid a evoked by dietary cholesterol is associated with increased atherosclerosis in mice.
BACKGROUND
Elevated serum amyloid A (SAA) levels are associated with increased cardiovascular risk. SAA levels can be increased by dietary fat and cholesterol. Moreover, SAA can cause lipoproteins to bind extracellular vascular proteoglycans, a process that is critical in atherogenesis. Therefore, we hypothesized that diet-induced increases in SAA would increase atherosclerosis independent of their effect on plasma cholesterol levels.


RESULTS
Female LDL-receptor-null (LDLR-/-) mice were fed high-saturated fat diets (21%, wt/wt), with or without added cholesterol (0.15%, wt/wt), for 10 weeks. Compared with chow-fed controls, the high-fat diets increased plasma SAA levels. Addition of cholesterol further increased SAA levels 2-fold (P<0.05) without further increasing plasma cholesterol levels. Addition of dietary cholesterol also increased atherosclerosis (P<0.05). Four lines of evidence suggest that SAA actually might cause atherosclerosis: (1) SAA levels when mice were euthanized correlated with the extent of atherosclerosis (r=0.49; P<0.02); (2) SAA levels after 5 weeks of diet correlated with the extent of atherosclerosis at 10 weeks (r=0.66; P<0.01); (3) binding of HDL from these animals to proteoglycans in vitro was related to the HDL-SAA content (r=0.65; P<0.01); and (4) immunoreactive SAA was present in lesion areas enriched with both proteoglycans and apolipoprotein A-I, the major HDL apolipoprotein.


CONCLUSIONS
Addition of cholesterol to a high-fat diet increased plasma SAA levels and atherosclerosis independent of an adverse effect on plasma lipoproteins, consistent with the hypothesis that SAA may promote atherosclerosis directly by mediating retention of SAA-enriched HDL to vascular proteoglycans.
Lewis
Katherine E
KE
Department of Medicine, University of Washington, Seattle, Wash 98195-6426, USA.
Kirk
Elizabeth A
EA
McDonald
Thomas O
TO
Wang
Shari
S
Wight
Thomas N
TN
O'Brien
Kevin D
KD
Chait
Alan
A
D000818:Animals; D001011:Aorta / Q000737:chemistry / Q000473:pathology; D001018:Aortic Diseases / Q000097:blood / Q000139:chemically induced / Q000473:pathology; D016632:Apolipoprotein A-I / Q000032:analysis; D001161:Arteriosclerosis / Q000097:blood / Q000139:chemically induced* / Q000473:pathology; D058578:Biglycan; D002784:Cholesterol / Q000097:blood; D002791:Cholesterol, Dietary / Q000494:pharmacology* / Q000633:toxicity; D004036:Diet, Atherogenic; D016326:Extracellular Matrix Proteins; D005260:Female; D008075:Lipoproteins, HDL / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D011509:Proteoglycans / Q000032:analysis / Q000378:metabolism; D011973:Receptors, LDL / Q000172:deficiency / Q000235:genetics; D000685:Serum Amyloid A Protein / Q000032:analysis*; D000683:Serum Amyloid P-Component / Q000032:analysis; D014280:Triglycerides / Q000097:blood
D016632:Apolipoprotein A-I; C546885:Bgn protein, mouse; D058578:Biglycan; D002791:Cholesterol, Dietary; D016326:Extracellular Matrix Proteins; D008075:Lipoproteins, HDL; D011509:Proteoglycans; D011973:Receptors, LDL; D000685:Serum Amyloid A Protein; D000683:Serum Amyloid P-Component; D014280:Triglycerides; D002784:Cholesterol